Evidence map›Paper›PMID 40489125›Full record

ArticleFuture science OA2025

Utilization, perceived benefits and concerns regarding robotic technologies among community pharmacists.

Anan S Jarab, Ahmad Z Al Meslamani, Walid Al-Qerem, Yazid N Al Hamarneh, Amal Akour

Abstract read
In one paragraph

Article in Future science OA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Identifying Measurement Dimensions of Users' Benefit-Risk Perceptions of AI in Healthcare: A Scoping Review.Inquiry : a journal of medical care organization, provision and financing
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anan S JarabCollege of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.
Ahmad Z Al MeslamaniCollege of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.
Walid Al-QeremDepartment of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.
Yazid N Al HamarnehDepartment of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
Amal AkourDepartment of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.ORCID 0000-0002-2789-8514

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRobotic technology is being rapidly adopted worldwide. The purpose of this study was to quantify the prevalence of robotic technology use among UAE community pharmacists, evaluate their perceived benefits and concerns, and identify factors that predict heightened concern levels. RESEARCH DESIGN AND

methodsThe present study utilized a validated self-administered survey, which was distributed in person to community pharmacists in different regions of Abu Dhabi and other Emirates. The questionnaire comprised sociodemographic and job‑related items, an operational definition of robotics, a 5‑point Likert scale on perceived benefits, a 4‑point Likert scale on perceived concerns (recoded to a 0-14 score), and a checklist of potential robotic pharmacy services.

resultsPharmacists holding only a bachelor's degree and pharmacy owners reported higher median concern scores than those with postgraduate degrees and pharmacists in charge, respectively. Additionally, pharmacists without training on robotic systems and those with heavier workloads dispensing ≥30 prescriptions per day or serving ≥10 patients per day also showed significantly greater concerns than their counterparts.

conclusionIt is necessary to implement training initiatives aimed at enhancing awareness and understanding of robotic technologies among pharmacists.

Indexed as

community pharmaciesperceived benefitsperceived concernspharmacistsRoboticsservices

Identifiers

PMID40489125
PMCPMC12150628

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.